Prostate cancer : imaging, management and screeningSCHRÖDER, Fritz.The Prostate. 1992, issn 0270-4137, 169 p., SUP4Conference Proceedings

The molecular biology of urological tumorsTRAPMAN, J.The Prostate. 1992, pp 159-169, issn 0270-4137, SUP4Conference Paper

To screen or not to screen ?DENIS, L. J.The Prostate. 1992, pp 63-70, issn 0270-4137, SUP4Conference Paper

Magnetic resonance imaging in carcinma of the prostatePOLLACK, H. M; SCHNALL, M. D.The Prostate. 1992, pp 17-31, issn 0270-4137, SUP4Conference Paper

Quality of life in prostate cancer patientsFOSSÅ, S. D; KAASA, S; CALAIS DE SILVA, F et al.The Prostate. 1992, pp 145-148, issn 0270-4137, SUP4Conference Paper

The TNM classification of prostate cancerSCHRÖDER, F. H; HERMANEK, P; DENIS, L et al.The Prostate. 1992, pp 129-138, issn 0270-4137, SUP4Conference Paper

Indications and techniques of prostate biopsiesANDERSSON, L.The Prostate. 1992, pp 115-118, issn 0270-4137, SUP4Conference Paper

Round table discussionThe Prostate. 1992, pp 59-62, issn 0270-4137, SUP4Conference Paper

What is progression in prostate cancer ?NEMLING, D. W. W.The Prostate. 1992, pp 139-143, issn 0270-4137, SUP4Conference Paper

Casodex : a pure non-steroidal anti-androgen used as monotherapy in advanced prostate cancerTYRRELL, C. J.The Prostate. 1992, pp 97-104, issn 0270-4137, SUP4Conference Paper

A rationale for the use of non-steroidal anti-androgens in the management of prostate cancerBENSON, R. C.The Prostate. 1992, pp 85-90, issn 0270-4137, SUP4Conference Paper

Magnetic resonance spectroscopy in prostate disease : diagnostic possibilities and future developmentsPERINCHERY NARAYAN; KURHANEWICZ, J.The Prostate. 1992, pp 43-50, issn 0270-4137, SUP4Conference Paper

Rectal examination and ultrasonography in the diagnosis of prostate cancerCOONER, W. H.The Prostate. 1992, pp 3-10, issn 0270-4137, SUP4Conference Paper

The management of bladder outlet obstruction due to prostate cancer, untreated and after endocrine treatmentMONTIE, J. E.The Prostate. 1992, pp 153-157, issn 0270-4137, SUP4Conference Paper

The management of incidental T1aG1 (TNM 1987) prostate cancerSOLOWAY, M. S; ALTWEIN, J. E.The Prostate. 1992, pp 149-151, issn 0270-4137, SUP4Conference Paper

Complete androgen blockade in prostate cancer : an overview of randomized trialsDALESIO, O.The Prostate. 1992, pp 111-114, issn 0270-4137, SUP4Conference Paper

DNA content/ploidy as prognostic factors in prostate cancerLIEBER, M. M.The Prostate. 1992, pp 119-124, issn 0270-4137, SUP4Conference Paper

Estramustine phosphate and other cytotoxic drugs in the treatment of poor prognostic advanced prostate cancerJANKNEGT, R. A.The Prostate. 1992, pp 105-110, issn 0270-4137, SUP4Conference Paper

Local staging of prostate cancer with transrectal ultrasound : a literature reviewLORENTZEN, T; NERSTROM, H; IVERSEN, P et al.The Prostate. 1992, pp 11-16, issn 0270-4137, SUP4Conference Paper

Preliminary results of three-dimensional reconstruction of previously imaged prostatesSESTERHENN, I. A; MOSTOFI, F. K; MATTREY, R. R et al.The Prostate. 1992, pp 33-41, issn 0270-4137, SUP4Conference Paper

Prostate specific antigen in diagnosis, staging, and follow-up of prostate cancerCOOPER, E. H.The Prostate. 1992, pp 125-128, issn 0270-4137, SUP4Conference Paper

Prostati intraepithelial neoplasia (PIN) : morphological clinical significanceMOSTOFI, F. K; SESTERHENN, I. A; DAVIS, C. J et al.The Prostate. 1992, pp 71-77, issn 0270-4137, SUP4Conference Paper

The natural history of locally confined prostate cancer : a reviewRAIR, W. R.The Prostate. 1992, pp 79-84, issn 0270-4137, SUP4Conference Paper

The position of cyproterone acetate (CPA), a steroidal anti-androgen, in treatment of prostate cancerDE VOOGT, H. J.The Prostate. 1992, pp 91-95, issn 0270-4137, SUP4Conference Paper

Volume of normal prostate, of prostate cancer, and of benign prostatic hyperplasia : are correlations with prostate specific antigen clinically useful ?CLEMENTS, R; PENNEY, M. D; ETHERINGTON, R. J et al.The Prostate. 1992, pp 51-57, issn 0270-4137, SUP4Conference Paper